Meta-Flux
AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.
About
Meta-Flux develops an AI-driven platform that models disease biology to improve preclinical drug development. The platform integrates genetic, proteomic, and metabolic data to simulate biological systems and predict how potential drugs will behave, helping researchers identify viable targets, validate mechanisms of action, and make faster, evidence-based go/no-go decisions before entering costly clinical stages. Their goal is to increase accuracy in drug development, ensuring that successful drugs help the right people. Teams look it up for Biotechnology, HealthTech, Drug Discovery.
Frequently asked
What does Meta-Flux do?
Meta-Flux is a Biotechnology company that offers Platform. Teams look it up for HealthTech, Drug Discovery, AI. It is based in Dublin, Ireland and was founded in 2021. Public records show $102M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Meta-Flux raised?
Meta-Flux has raised a total of $102M in funding. The most recent round on record is Pre-Seed.
Where is Meta-Flux headquartered?
Meta-Flux is headquartered in Dublin, Ireland.
When was Meta-Flux founded?
Meta-Flux was founded in 2021.
What industry does Meta-Flux operate in?
Meta-Flux operates in Biotechnology, HealthTech, Drug Discovery, AI, Machine Learning.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.